Basic Information
Basic information for MIR646HG-217-36aa
Peptide Name MIR646HG-217-36aa
Genome Position chr20:60126056-60126163[+]
Species Human
Peptide Sequence MVDCRGQEGAGSPCCCRRKDEGWLSSTFQISQEHLF
Peptide Length 36
Unique No (MIR646HG-213-36aa,MIR646HG-215-36aa,MIR646HG-222-36aa,MIR646HG-229-36aa,MIR646HG-234-36aa,MIR646HG-246-36aa,MIR646HG-253-36aa,MIR646HG-254-36aa)
Grand Average of Hydropathicity -0.5833
Relative Molecular Mass 4693.12
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000228340;MIR646HG
Transcript ID/Name ENST00000654038;MIR646HG-217
Transcript Length 1422
Coding Ability 0.3319
DNA Sequence Corresponding to Peptide ATGGTGGACTGCAGGGGCCAGGAAGGTGCAGGAAGCCCCTGCTGCTGCAGGAGAAAGGATGAAGGATGGTTATCTTCCACCTTCCAAATCTCACAGGAACACCTCTTC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :